According to a new study published in PLOS ONE, which looked at survey data from the UK Office of National Statistics, masks were found to be ineffective after the first Omicron wave. You can read the original article here. When the COVID-19 pandemic first started, mask use was advised as
“They will not silence me”: says the doctor who discovered omicron while stating she was pressured not to reveal it’s mild. A serious illness is one in which we see acute pulmonary respiratory infections, we saw that with Delta – but not with Omicron.
Shocking statistics regarding Canada’s Omicron hospitalizations has come to light recently. The Premier of Alberta has claimed a staggering 60% disparity between the actual figures.
A US-based cardiologist termed Omicron variant as nothing more than a “seasonal cold virus”, and has warned against “overreaction and over-reach” by government agencies. He claimed that Omicron is “literally” the vaccine that vaccine companies could not make. He also said that the actions of government agencies are causing panic
One of the most vaccinated nation Israel may switch to the policy of herd immunity to be achieved through mass infection as the vaccines have failed to curb the rising cases of COVID-19 Omicron variant.
The mystery of the origin of omicron strain of COVID-19 is raising new questions about the still undetermined origin of the coronavirus outbreak and whether it leaked from a Chinese research laboratory in Wuhan in 2019.
The Food and Drug Administration warned on Tuesday that COVID-19 antigen tests may be significantly less able to detect Omicron, the rapidly escalating variant of COVID.
After the Omicron variant managed to hit the headlines, the CEOs and major shareholders of the Pfizer and Moderna saw a profit of a combined $10.31 billion, as per data compiled by the UK-based Global Justice Now.
A group of seven Germans were infected with the Omicron variant in early December even after having been fully vaccinated and getting the off-lauded booster shots from Moderna, AstraZeneca and BioNTech.
